Interestingly, approximately 27.6% of the CD11b+ cells (13.0% in total viable cells) and 2.6% of total CD11b+ cells (0.3% in total viable cells) were tiMDSCs on day 7 and 14 after tumor cell inoculation, respectively (Figure 7). The gene discussed is ITGAM; the disease is neoplasm.